Advertisement

The Scientist

» clinical trials and microbiology

Most Recent

image: FDA OKs Early Stage Trials

FDA OKs Early Stage Trials

By | June 5, 2012

The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.

1 Comment

image: Rapid Bird Flu Test

Rapid Bird Flu Test

By | June 4, 2012

New PCR assay can detect more than 40 strains of H5N1 in a single go.

1 Comment

image: Best in Industry, 2012

Best in Industry, 2012

By | June 1, 2012

Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of drugs, research tools, and cutting-edge innovations.

2 Comments

image: Interfering with Resistance

Interfering with Resistance

By | June 1, 2012

Drug efficacy and resistance mechanisms shine a light on how drugs enter cells, which could facilitate the development of new sleeping-sickness treatments. 

0 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Microbiology Goes High-Tech

Microbiology Goes High-Tech

By | June 1, 2012

Out with toothpicks and pipettors; in with automation.

0 Comments

image: Trials Overlook Cancer Spread

Trials Overlook Cancer Spread

By | May 30, 2012

One cancer researcher says that by focusing solely on stalling cancer growth, clinical trials are failing some potentially life-saving drugs that prevent metastasis.

0 Comments

image: Overhauling Industry-Sponsored Studies

Overhauling Industry-Sponsored Studies

By | May 23, 2012

Major pharmaceutical companies have agreed to a handful of recommendations aimed at increasing the transparency of clinical trials they fund.

1 Comment

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

image: Approving

Approving

By | May 14, 2012

The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
BioTek
BioTek
Advertisement
The Scientist
The Scientist